GB991293A - Taste-masked pharmaceutical preparations containing glutarimide derivatives - Google Patents

Taste-masked pharmaceutical preparations containing glutarimide derivatives

Info

Publication number
GB991293A
GB991293A GB41947/61A GB4194761A GB991293A GB 991293 A GB991293 A GB 991293A GB 41947/61 A GB41947/61 A GB 41947/61A GB 4194761 A GB4194761 A GB 4194761A GB 991293 A GB991293 A GB 991293A
Authority
GB
United Kingdom
Prior art keywords
alginate
preparations
taste
pharmaceutical preparations
glutarimide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB41947/61A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba AG filed Critical Ciba AG
Publication of GB991293A publication Critical patent/GB991293A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Taste-masked pharmaceutical preparations for oral administration, which have hypnotic, sedative and anticonvulsive properties, comprise a therapeutically active compound of the formula <FORM:0991293/A5-A6/1> in which R represents an alkyl group containing up to 5 carbon atoms and R1 represents the phenyl or para-aminophenyl group, an alginate and a liquid pharmaceutically suitable carrier. Suitable active compounds are described in Specifications 720,198 and 829,415; the preferred compounds are a-ethyl-a -phenyl-glutarimide and a -ethyl-a -(p-aminophenyl)-glutarimide, which are preferably used in hydrated or finely divided form. The alginate may be used in the form of an ammonium or alkali metal, e.g. sodium or potassium, salt, or an alkylene glycol, e.g. propylene glycol, ester where the alkylene group contains up to 5 carbon atoms. If an alkali metal alginate is used, this may be rendered water-resistant by reacting, in part, with a salt such as calcium chloride, calcium citrate or aluminium chloride. The preparations may optionally contain a thickener, e.g. hydrated magnesium aluminium silicate or a cellulose derivative, and also preservatives, stabilizing agents, wetting or emulsifying agents, colouring and flavouring agents and other therapeutically active substances. The preparations are preferably used in the form of aqueous suspensions.
GB41947/61A 1960-11-23 1961-11-23 Taste-masked pharmaceutical preparations containing glutarimide derivatives Expired GB991293A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7117660A 1960-11-23 1960-11-23

Publications (1)

Publication Number Publication Date
GB991293A true GB991293A (en) 1965-05-05

Family

ID=22099739

Family Applications (1)

Application Number Title Priority Date Filing Date
GB41947/61A Expired GB991293A (en) 1960-11-23 1961-11-23 Taste-masked pharmaceutical preparations containing glutarimide derivatives

Country Status (2)

Country Link
BE (1) BE610635A (en)
GB (1) GB991293A (en)

Also Published As

Publication number Publication date
BE610635A (en) 1962-05-22

Similar Documents

Publication Publication Date Title
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
FR2430410A1 (en) PHENETHANOLAMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
GB1277132A (en) Pyridobenzo-diazepine derivatives
SE7906000L (en) THERAPEUTICALLY ACTIVE, SUBSTITUTED PIPERIDINES AND PYRROLIDINES
ES462658A1 (en) Analgesic compounds
ES8102561A1 (en) 1-Aryl-4- gamma -arylsulphonyl-3-aminopropoxy-1H-pyrazoles and their use as hypolipemiant and hypocholesterolemiant agents
FR2359144A1 (en) SALTS OF CLAVULANIC ACID FOR USE AS MEDICINAL PRODUCTS
DE3170937D1 (en) 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
BE825653A (en) ANTIBIOTIC PHARMACEUTICAL COMPOSITIONS CONTAINING THE SODIUM SALT OF 7- (D-2-FORMYLOXY-2- PHENYLACE TAMIDO -3- 1-METHYL-14-TETRAZOLE-5-YL-THIOMETHYL) -3-CEPHEM-40-CARBOXYLIC
AU6250680A (en) Phosphono-hydroxy-acetic acid
GB2000025A (en) Nitroimidazole formulations
GB991293A (en) Taste-masked pharmaceutical preparations containing glutarimide derivatives
NZ238022A (en) Indole derivatives and pharmaceutical compositions
GB1163870A (en) Anti-Seborrhocic Compositions Suitable for Oral Administration
FR2363560A1 (en) NEW COMPOUND WITH ANALGESIC ACTION AND THERAPEUTIC COMPOSITIONS IN CONTAINER
GB1437788A (en) Therapeutic compositions
DE2963792D1 (en) Indanyloxamic derivatives, their preparation and pharmaceutical compositions containing them
SE8303719L (en) EBURNAN OXIMIZE DERIVATIVES, PROCEDURE FOR PREPARING THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE ASSOCIATIONS
IL67672A0 (en) Penicillin derivatives,their preparation and pharmaceutical compositions containing them
GB971046A (en) Substituted naphthol derivatives
IL82122A0 (en) Stable injectable antiemetic compositions containing benzamide derivatives
GB1251935A (en)
IL70272A0 (en) Acridanone derivatives,their manufacture and pharmaceutical compositions containing them
GB1255591A (en) Compositions for use as eye drops or eye lotion
GB1312095A (en) Alkanolamine derivatives